Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology.
Fraser AG, Daubert JC, Van de Werf F, Estes NA 3rd, Smith SC Jr, Krucoff MW, Vardas PE, Komajda M; participants. Fraser AG, et al. Among authors: van de werf f. Eur Heart J. 2011 Jul;32(13):1673-86. doi: 10.1093/eurheartj/ehr171. Epub 2011 May 14. Eur Heart J. 2011. PMID: 21572115
Implementing the new European Regulations on medical devices-clinical responsibilities for evidence-based practice: a report from the Regulatory Affairs Committee of the European Society of Cardiology.
Fraser AG, Byrne RA, Kautzner J, Butchart EG, Szymański P, Leggeri I, de Boer RA, Caiani EG, Van de Werf F, Vardas PE, Badimon L. Fraser AG, et al. Among authors: de boer ra, van de werf f. Eur Heart J. 2020 Jul 14;41(27):2589-2596. doi: 10.1093/eurheartj/ehaa382. Eur Heart J. 2020. PMID: 32484542
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F. Janssens S, et al. Among authors: van cleemput j, van de werf f. Lancet. 2006 Jan 14;367(9505):113-21. doi: 10.1016/S0140-6736(05)67861-0. Lancet. 2006. PMID: 16413875 Clinical Trial.
STREAM characterisation correction.
Armstrong PW, Van de Werf F. Armstrong PW, et al. Among authors: van de werf f. Lancet. 2017 May 27;389(10084):2102. doi: 10.1016/S0140-6736(17)31335-1. Lancet. 2017. PMID: 28561000 No abstract available.
CardioScape mapping the cardiovascular funding landscape in Europe.
Pries AR, Naoum A, Habazettl H, Dunkel M, Preissner R, Coats CJ, Tornada A, Orso F, Van de Werf F, Wood DA; CardioScape steering committee; Van de Werf F, Wood DA, O'Kelly S, Craven J, Coats A, Sipido K, De Backer D, Wallentin L, Hasenfuss G, Della Sala L, Leggeri I; CardioScape scientific committee; Wood DA, Van de Werf F, Jaarsma T, Elliott P, Pries AR, Madonna R, Kjeldsen K, Maggioni AP, Franco OH, Hills S, Pugliese F, De Bacquer D. Pries AR, et al. Among authors: de bacquer d, de backer d, van de werf f. Eur Heart J. 2018 Jul 1;39(25):2423-2430. doi: 10.1093/eurheartj/ehx106. Eur Heart J. 2018. PMID: 28449050
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.
Scirica BM, Bonaca MP, Braunwald E, De Ferrari GM, Isaza D, Lewis BS, Mehrhof F, Merlini PA, Murphy SA, Sabatine MS, Tendera M, Van de Werf F, Wilcox R, Morrow DA; TRA 2°P-TIMI 50 Steering Committee Investigators. Scirica BM, et al. Among authors: de ferrari gm, van de werf f. Lancet. 2012 Oct 13;380(9850):1317-24. doi: 10.1016/S0140-6736(12)61269-0. Epub 2012 Aug 26. Lancet. 2012. PMID: 22932716 Clinical Trial.
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, Van de Werf F, Downey WE, Scirica BM, Murphy SA, Antman EM; TRITON-TIMI 38 Investigators. Wiviott SD, et al. Among authors: van de werf f. Lancet. 2008 Apr 19;371(9621):1353-63. doi: 10.1016/S0140-6736(08)60422-5. Epub 2008 Apr 2. Lancet. 2008. PMID: 18377975 Clinical Trial.
759 results